Conceptual Bases of Application of Regenerative Technologies in Osteoarthritis and Avascular Necrosis of the Hip and Knee Joints
ARTICLE PDF (Українська)

Keywords

osteoarthritis; avascular necrosis; hip joint; knee joint; regenerative technologies.

How to Cite

Holiuk, Y., Poliachenko, Y., Strafun, S., Haiovych, I., & Pshenychnyi, T. (2021). Conceptual Bases of Application of Regenerative Technologies in Osteoarthritis and Avascular Necrosis of the Hip and Knee Joints. TERRA ORTHOPAEDICA, (3(110), 20-27. https://doi.org/10.37647/0132-2486-2021-110-3-20-27

Abstract

Summary. We have developed a working classification of biotechnological products, defined the conceptual basis for their use in osteoarthritis and avascular necrosis of the hip and knee joints, and identified areas for further study and analysis of the results of the use of regenerative technologies in these diseases. The main conceptual principles of the use of regenerative technologies in osteoarthritis and avascular necrosis of the hip and knee joints include both the improvement of techniques for the introduction of biotechnological products and further study and improvement of biotechnological products used to treat these diseases, and a differentiated approach should combine the principles of evidence-based and personalized medicine.

https://doi.org/10.37647/0132-2486-2021-110-3-20-27
ARTICLE PDF (Українська)

References

Alderman DD, Alexander RW. Advanced in Regenerative Medicine: High-density Platelet-rich Plasma and Stem Cell Prolotherapy For Musculoskeletal Pain. Practical Pain Management. 2011;11(8):49-63.

Hauser R, Woldin B. Treating Osteoarthritic Joints Using Dextrose Prolotherapy and Direct Bone Marrow Aspirate Injection Therapy. The Open Arthritis Journal. 2014;7(1):1-9. DOI: 10.2174/1876539401407010001.

Lubis AMT, Lubis VK. Adult bone marrow stem cells in cartilage therapy. Acta Medica Indonesiana – Indonesian J Int Med 2012;44(1):62-8.

Rabago D, Zgierska A, Fortney L, Kijowski R, Mundt M, Ryan M, et al. Hypertonic dextrose injections (prolotherapy) for knee osteoarthritis: results of a single-arm uncontrolled study with 1-year follow-up. J Altern Complement Med 2012;(4):408-14. DOI: 10.1089/ACM.2011.0030.

Rabago D, Patterson JJ, Mundt M, Kijowski R, Grettie J, Segal NA, et al. Dextrose prolotherapy for knee osteoarthritis: a randomized controlled trial. Ann Fam Med 2013;11(3):229-37. DOI: 10.1370/afm.1504.

Davatchi F, Abdollahi BS, Mohyeddin M, Shahram F, Nikbin B. Mesenchymal stem cell therapy for knee osteoarthritis: preliminary report of four patients. Int J Rheum Dis 2011;14:211-5. DOI: 10.1111/j.1756-185X.2011.01599.x.

Centeno CJ, Busse D, Kisiday J, Keohan C, Freeman M, Karli D. Increased knee cartilage volume in degenerative joint disease using percutaneously implanted,autologous mesenchymal stem cells. Pain Phys 2008;11:343-53.

Emadedin M, Aghdami N, Taghiyar L, et al. Intra-articular injection of autologous mesenchymal stem cells in six patients with knee osteoarthritis. Arch Iran Med 2012; 15 (7): 422-8.

Getgood A, Henson F, Skelton C, Herrera E, Brooks R, Fortier LA, et al. The augmentation of a collagen/glycosaminoglycan biphasic osteochondral scaffold with platelet-rich plasma and concentrated bone marrow aspirate for osteochondral defect repair in sheep: a pilot study. Cartilage 2012;3(4):351-63. DOI: 10.1177/1947603512444597.

Centeno ChJ, A Jerome M, Pastoriza SM, Shapiro Sh, Physician P. Use of Bone Marrow Concentrate to Treat Pain and Musculoskeletal Disorders: An Academic Delphi Investigation. 2021;24(3):263-73. DOI:10.36076/ppj.2021/24/263.

Centeno ChJ, Pastoriza SM. Past, Current and Future Interventional Orthobiologics techniques and how they relate to regenerative rehabilitation: a clinical commentary. The International Journal of Sports Physical Therapy. 2020;15(2):301-25. DOI: 10.26603/ijspt20200301 /2020.

Manchikanti L, Centeno ChJ, Atluri S, Albers ShL, Shapiro Sh, Malanga GA, et al. Bone Marrow Concentrate (BMC) Therapy in Musculoskeletal Disorders: Evidence-Based Policy Position Statement of American Society of Interventional Pain Physicians (ASIPP). Pain Physician. 2020;23(2):E85-E131 DOI: 10.36076/ppj.2020/23/E85.

Centeno Ch, Markle J, Dodson E, Stemper I, Williams Ch, Hyzy M, et al. Symptomatic anterior cruciate ligament tears treated with percutaneous injection of autologous bone marrow concentrate and platelet products: A non-controlled registry study. Journal of Translational Medicine. 2018;16(1):246. DOI: 10.1186/s12967-018-1623-3.

Centeno CJ, Hyzy MW, Williams CJ. Bone Marrow Derived Stem Cells and Their Application in Pain Medicine. In: Diwan S, Deer T, editor. Advanced Procedures for Pain Management. Springer: Cham; 2018. P. 469-487. DOI: 10.1007/978-3-319-68841-1_40.

Centeno ChJ, Al-Sayegh H, Freeman MD, Smith J. Correction to: A multi-center analysis of adverse events among two thousand, three hundred and seventy two adult patients undergoing adult autologous stem cell therapy for orthopaedic conditions. International Orthopaedics. 2018;42(1):223. DOI: 10.1007/s00264-017-3680-2.

Centeno ChJ, Al-Sayegh H, Freeman MD, Smith J. A multi-center analysis of adverse events among two thousand, three hundred and seventy two adult patients undergoing adult autologous stem cell therapy for orthopaedic conditions. International Orthopaedics. 2016;40:1755-65. DOI: 10.1007/s00264-016-3162-y.

Linetsky F, Alfredson H, Crane D, Centeno ChJ. Treatment of Chronic Painful Musculoskeletal Injuries and Diseases with Regenerative Injection Therapy (RIT): Regenerative Injection Therapy Principles and Practice. In: Treatment of Chronic Pain by Integrative Approaches. New York, NY: Springer; 2015:145-168. DOI: 10.1007/978-1-4939-1821-8_12

Centeno CJ, Pitts J, Al-Sayegh H, Freeman MD. Efficacy and safety of bone marrowconcentrate for osteoarthritis of the hip; treatment registry results for 196 patients. J Stem Cell Res Ther. 2014;4(10):1-7. DOI: 10.4172/2157-7633.1000242.

Arden N, Blanco FJ, Bruyère O, Cooper C, Guermazi A, Hayashi D, et al. Atlas of Osteoarthritis. London: Springer Healthcare Ltd.: 2014:11-19.

Graham P. Avascular Necrosis and Bone Infarcts of the Knee. Orthop Nurs. 2020 Jan/Feb;39(1):59-61. DOI: 10.1097/NOR.0000000000000631.

Steffen RT, Athanasou NA, Gill HS, Murray DW. Avascular necrosis associated with fracture of the femoral neck after hip resurfacing: histological assessment of femoral bone from retrieval specimens. The Journal of bone and joint surgery. British volume. 2010;92(6):787-93. DOI: 10.1302/0301-620X.92B6.23377.

Bagan JV, Murillo J, Jimenez Y, Poveda R, Milian MA, Sanchis JM, et al. Avascular jaw osteonecrosis in association with cancer chemotherapy: series of 10 cases. Journal of oral pathology & medicine: official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology. 2005;34(2):120-3. DOI: 10.1111/j.1600-0714.2004.00269.x.

Khan AA, Sándor GK, Dore E, Morrison AD, Alsahli M, Amin F, et al. Canadian Taskforce on Osteonecrosis of the Jaw. Bisphosphonate associated osteonecrosis of the jaw. The Journal of rheumatology, 2009;36(3):478-90. DOI: 10.3899/jrheum.080759/.

https://blog.rehabselect.net/10-startling-statistics-on-joint-replacement surgery.

Houdek MT, Wyles CC, Martin JR, Sierra RJ. Stem cell treatment for avascular necrosis of the femoral head: current perspectives. Stem Cells and Cloning: Advances and Applications. 2014;7:65-70. DOI: 10.2147/SCCAA.S36584.

Gangji V, Toungouz M, Hauzeur J-Ph. Stem cell therapy for osteonecrosis of the femoral head. Expert Opinion on Biological Therapy. 2005;5(4):437-42 DOI: 10.1517/14712598.5.4.437.

Centeno CJ, Kisiday J, Freeman M, Schultz JR. Partial regeneration of the human hip via autologous bone marrow nucleated cell transfer: A case study. Pain Physician. 2006;9:253-256.

Evans ChH. Advances in Regenerative Orthopedics. Mayo Clin Proc. 2013;88(11):1323-39. DOI: 10.1016/j.mayocp.2013.04.027.

Roseti L, Parisi V, Petretta M, Cavallo C, Desando G, Bartolotti I, et al. Scaffolds for BoneTissue Engineering: State of the art and new perspectives. Materials Scienc and Engineering. 2017;78:1246-62. DOI: 10.1016/j.msec.2017.05.017.

Dhandayuthapani B, Yoshida Y, MaekawaT, Kumar DS. Polymeric Scaffolds in Tissue Engineering Application: A Review. International Journal of Polymer Science. 2011;(2011):19.

Xie X, Zhang Ch, Tuan RS. Biology of platelet-rich plasma and its clinical application in cartilage repair. Arthritis Res Ther. 2014;16(1):20. DOI: 10.1186/ar4493.

Centeno ChJ, Williams ChJ, Hyzy M. Interventional orthopedics in pain medicine practice. Techniques in Regional Anesthesia [amp] Pain Management. 2016;19(1-2):26-31. DOI: 10.1053/j.trap.2016.09.005.

Hackett GS, Hemwall GA, Montgomery GA. Ligament and Tendon Relaxation Treated by Prolotherapy. 3th ed. Springfield, Illinois(U.S.A.):CHARLESC THOMAS PUBLISHER;1958.152 p.

https://centenoschultz.com/what-is-interventional-orthopedics/.

Gordin K. Comprehensive Scientific Overview on the Use of Platelet Rich Plasma Prolotherapy (PRPP). Journal of Prolotherapy. 2011;3(4):813-25.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.